Total Payments
$10,240
2023 Payments
$17.10
Companies
17
Transactions
63
Payment Breakdown by Category
Consulting$7,550 (73.7%)
Food & Beverage$1,557 (15.2%)
Other$625.00 (6.1%)
Travel$347.11 (3.4%)
Education$160.79 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $7,550 | 6 | 73.7% |
| Food and Beverage | $1,557 | 47 | 15.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $625.00 | 2 | 6.1% |
| Travel and Lodging | $347.11 | 2 | 3.4% |
| Education | $160.79 | 6 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $4,946 | 7 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $3,150 | 5 | $0 (2022) |
| GENZYME CORPORATION | $625.00 | 2 | $0 (2021) |
| COMSORT, Inc | $300.00 | 2 | $0 (2017) |
| PFIZER INC. | $253.97 | 22 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $191.00 | 8 | $0 (2018) |
| Daiichi Sankyo Inc. | $162.07 | 3 | $0 (2023) |
| TESARO, Inc. | $121.69 | 1 | $0 (2017) |
| Cardinal Health 110 LLC | $100.00 | 1 | $0 (2020) |
| Epizyme, Inc., | $99.99 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $17.10 | 1 | Daiichi Sankyo Inc. ($17.10) |
| 2022 | $371.92 | 11 | AstraZeneca Pharmaceuticals LP ($106.82) |
| 2021 | $454.81 | 4 | GENZYME CORPORATION ($300.00) |
| 2020 | $260.25 | 4 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2019 | $7,778 | 10 | Incyte Corporation ($4,821) |
| 2018 | $376.40 | 13 | Novartis Pharmaceuticals Corporation ($175.90) |
| 2017 | $981.22 | 20 | GENZYME CORPORATION ($325.00) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/05/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/10/2022 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Oncology | ||||||
| 10/25/2022 | Lilly USA, LLC | CYRAMZA (Drug), VERZENIO, RETEVMO | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Oncology | ||||||
| 09/22/2022 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $90.28 | General |
| Category: Oncology | ||||||
| 09/21/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Oncology | ||||||
| 09/14/2022 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $18.21 | General |
| Category: Oncology | ||||||
| 07/22/2022 | Genentech USA, Inc. | GAZYVA (Biological), VENCLEXTA, POLIVY | Food and Beverage | In-kind items and services | $28.34 | General |
| Category: BioOncology | ||||||
| 07/13/2022 | Astellas Pharma US Inc | PADCEV (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Oncology | ||||||
| 07/06/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: ONCOLOGY | ||||||
| 04/29/2022 | Daiichi Sankyo Inc. | ENHERTU (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: ONCOLOGY | ||||||
| 03/11/2022 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $19.76 | General |
| Category: Oncology | ||||||
| 02/28/2022 | Epizyme, Inc., | TAZVERIK (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2021 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2021 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Oncology | ||||||
| 06/15/2021 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 01/27/2021 | GENZYME CORPORATION | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| 08/07/2020 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: ONCOLOGY | ||||||
| 05/11/2020 | Cardinal Health 110 LLC | — | Consulting Fee | Cash or cash equivalent | $100.00 | General |
| 01/30/2020 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 01/16/2020 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2019 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $117.84 | General |
| Category: Oncology | ||||||
| 10/17/2019 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| 06/10/2019 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: ONCOLOGY | ||||||
| 04/08/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: Oncology | ||||||
| 02/14/2019 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $23.92 | General |
| Category: ONCOLOGY | ||||||
About Dr. Kent Difiore, M.D
Dr. Kent Difiore, M.D is a Hematology & Oncology healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649229618.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kent Difiore, M.D has received a total of $10,240 in payments from pharmaceutical and medical device companies, with $17.10 received in 2023. These payments were reported across 63 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($7,550).
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Salt Lake City, UT
- Active Since 05/08/2006
- Last Updated 12/27/2010
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1649229618
Products in Payments
- LYNPARZA (Drug) $2,800
- CALQUENCE (Drug) $333.12
- ELITEK (Drug) $325.00
- KEYTRUDA (Biological) $300.00
- IBRANCE (Drug) $211.43
- TASIGNA (Drug) $144.88
- Enhertu (Drug) $125.00
- JAKAFI (Drug) $125.00
- ZEJULA (Drug) $121.69
- TAZVERIK (Drug) $99.99
- Tarceva (Drug) $66.96
- Revlimid (Drug) $48.15
- Lenvima (Drug) $37.97
- JADENU (Drug) $36.16
- GAZYVA (Biological) $28.34
- IMBRUVICA (Drug) $24.48
- Xtandi (Drug) $20.89
- ENHERTU (Drug) $19.97
- PADCEV (Drug) $17.59
- INJECTAFER (Drug) $17.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Salt Lake City
Daniel Couriel, M.d, M.D
Hematology & Oncology — Payments: $325,752
Hematology & Oncology $325,752
Shiven Patel, Md, Mba, Facp, MD, MBA, FACP
Hematology & Oncology — Payments: $148,156
Hematology & Oncology $148,156
Dr. Finn Petersen, M.d, M.D
Hematology & Oncology — Payments: $125,159
Hematology & Oncology $125,159
Dr. Heloisa Soares, M.d, M.D
Hematology & Oncology — Payments: $124,078
Hematology & Oncology $124,078
Deborah Stephens, D.o, D.O
Hematology & Oncology — Payments: $83,112
Hematology & Oncology $83,112
Charles Parker, M.d, M.D
Hematology & Oncology — Payments: $69,288
Hematology & Oncology $69,288